Press Release from NCI: In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half

The latest press release from the National Cancer Institute

Having trouble viewing this email? View it as a Web page.

You are subscribed to Press Releases from the National Cancer Institute. New press releases are listed below.     In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half 06/15/2022 Results from the NCI-supported ANCHOR study show that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892